ROGER GARCEAU
CIK 1451767 · SVP & CMO · last filed 2025-06-13
ROGER GARCEAU is a SVP & CMO who has filed 30 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for TARA, was dated Jun 13, 2025. Across all open-market trades the lifetime net is −$4.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $128.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$128.7K
4
30
-$4.11M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TARA | Director | 33,000 | $3.90 | $128.7K | $0 | 8 | 2025-06-13 |
| ENTX | Director | — | $1.23 | — | $0 | 1 | 2024-01-03 |
| Entera Bio Ltd. (ENTXW) Delisted | Director | — | $0.00 | — | $0 | 2 | 2023-01-04 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | SVP & CMO | 0 | — | — | -$4.11M | 19 | 2015-02-24 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-13 | TARA | Grant (A) | — | $0 | EDGAR |
| 2024-06-10 | TARA | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | ENTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | TARA | Grant (A) | — | $0 | EDGAR |
| 2023-01-04 | Entera Bio Ltd. (ENTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | TARA | Grant (A) | — | $0 | EDGAR |
| 2022-01-11 | Entera Bio Ltd. (ENTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | TARA | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | TARA | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | TARA | Grant (A) | — | $0 | EDGAR |